(InDevR, Inc.) InDevR Inc., a leader in progressive analytical technologies, announced today that they have received 510(k) market clearance for their FluChip-8G Influenza A+B Assay from the United States Food and Drug Administration (FDA).
from EurekAlert! - Technology, Engineering and Computer Science http://bit.ly/2IRHQ2f
Wednesday, May 1, 2019
510(k) market clearance for FluChip-8G Influenza A+B Assay
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment